[go: up one dir, main page]

AU2549584A - Enhancing vaccines: antigenicity - Google Patents

Enhancing vaccines: antigenicity

Info

Publication number
AU2549584A
AU2549584A AU25495/84A AU2549584A AU2549584A AU 2549584 A AU2549584 A AU 2549584A AU 25495/84 A AU25495/84 A AU 25495/84A AU 2549584 A AU2549584 A AU 2549584A AU 2549584 A AU2549584 A AU 2549584A
Authority
AU
Australia
Prior art keywords
antigenicity
vaccines
enhancing
enhancing vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25495/84A
Inventor
Hans-Joachim Bengelsdorff
Dieter Bernhardt
Rudolf Mauler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of AU2549584A publication Critical patent/AU2549584A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU25495/84A 1983-03-10 1984-03-09 Enhancing vaccines: antigenicity Abandoned AU2549584A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833308458 DE3308458A1 (en) 1983-03-10 1983-03-10 METHOD FOR ADJUVING VACCINES
DE3308458 1983-03-10

Publications (1)

Publication Number Publication Date
AU2549584A true AU2549584A (en) 1984-09-13

Family

ID=6193028

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25495/84A Abandoned AU2549584A (en) 1983-03-10 1984-03-09 Enhancing vaccines: antigenicity

Country Status (5)

Country Link
EP (1) EP0121752A2 (en)
AU (1) AU2549584A (en)
DE (1) DE3308458A1 (en)
DK (1) DK93684A (en)
ES (1) ES530383A0 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US4770874A (en) * 1983-08-22 1988-09-13 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
DE3446515A1 (en) * 1984-12-20 1986-06-26 Behringwerke Ag, 3550 Marburg OIL ADJUVED VACCINE AND METHOD FOR THE PRODUCTION THEREOF
DE3875762T2 (en) * 1987-03-17 1993-05-13 Akzo Nv ADJUVANIC MIX.
US7202225B1 (en) 1993-10-15 2007-04-10 Emanuele R Martin Therapeutic delivery compositions and methods of use thereof
US6933286B2 (en) 1991-03-19 2005-08-23 R. Martin Emanuele Therapeutic delivery compositions and methods of use thereof
ES2189808T3 (en) * 1993-10-15 2003-07-16 Cytrx Corp THERAPEUTIC CONTRIBUTION COMPOSITIONS AND METHODS OF USE OF THE SAME.
EP1181937A3 (en) * 1994-08-09 2004-02-04 Cytrx Corporation Novel vaccine adjuvant and vaccine
BR0205774A (en) * 2002-02-27 2004-04-20 Fundacao De Amparo A Pesquisa Adjuvant system for antibody production, vaccine and use

Also Published As

Publication number Publication date
ES8606789A1 (en) 1985-10-01
EP0121752A2 (en) 1984-10-17
ES530383A0 (en) 1985-10-01
DK93684A (en) 1984-09-11
DE3308458A1 (en) 1984-09-13
DK93684D0 (en) 1984-02-23

Similar Documents

Publication Publication Date Title
AU2379984A (en) Coupled h. influenzae type b vaccine
AU2010383A (en) Immunogenic protein complex
AU550147B2 (en) Thymidinekinase-removed pseudorabies virus
AU568584B2 (en) Infectious bronchitis vaccines
AU552702B2 (en) Synthetic vaccines
AU1489188A (en) Novel vaccines
AU2549584A (en) Enhancing vaccines: antigenicity
GB2145419B (en) Vaccines
ZA844002B (en) Novel vaccines
AU557161B2 (en) Pseudorabies vaccine
AU7395987A (en) Vaccine
ZA858374B (en) Antigenic preparation
AU7121281A (en) Chlamydous vaccine
GB8531508D0 (en) Vaccine
GB2142334B (en) Immunogenic preparations
AU7453687A (en) Novel vaccines
ZA858789B (en) Vaccines
GB2137880B (en) Immunogenic compositions
GB8619804D0 (en) Vaccine
GB2144129B (en) Antigens as immunostimulant adjuvants
AU572178B2 (en) Vaccines with pseudo hepatitis-e/c antigens
AU578465B2 (en) Babesial vaccine
AU7243187A (en) Antigenic cell free supernatant
GB2104527B (en) Antingens as immunostimulant adjuvants
AU580569B2 (en) Immunization